Cardiomyopathy, Familial Hypertrophic, 13
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes.
|
30681346 |
2019 |
Cardiomyopathy, Familial Hypertrophic, 13
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.
|
27532257 |
2017 |
Cardiomyopathy, Familial Hypertrophic, 13
|
0.900 |
Biomarker
|
disease |
MGD |
Pathogenesis of depression- and anxiety-like behavior in an animal model of hypertrophic cardiomyopathy.
|
28235781 |
2017 |
Cardiomyopathy, Familial Hypertrophic, 13
|
0.900 |
Biomarker
|
disease |
MGD |
In Vivo Analysis of Troponin C Knock-In (A8V) Mice: Evidence that TNNC1 Is a Hypertrophic Cardiomyopathy Susceptibility Gene.
|
26304555 |
2015 |
Cardiomyopathy, Familial Hypertrophic, 13
|
0.900 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The genetics of dilated cardiomyopathy.
|
20186049 |
2010 |
Cardiomyopathy, Familial Hypertrophic, 13
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
A functional and structural study of troponin C mutations related to hypertrophic cardiomyopathy.
|
19439414 |
2009 |
Cardiomyopathy, Familial Hypertrophic, 13
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C.
|
18572189 |
2008 |
Cardiomyopathy, Familial Hypertrophic, 13
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
Cardiac troponin C-L29Q, related to hypertrophic cardiomyopathy, hinders the transduction of the protein kinase A dependent phosphorylation signal from cardiac troponin I to C.
|
16302972 |
2005 |
Cardiomyopathy, Familial Hypertrophic, 13
|
0.900 |
GeneticVariation
|
disease |
UNIPROT |
First mutation in cardiac troponin C, L29Q, in a patient with hypertrophic cardiomyopathy.
|
11385718 |
2001 |
Cardiomyopathy, Familial Hypertrophic, 13
|
0.900 |
GeneticVariation
|
disease |
CLINVAR |
|
|
|
Cardiomyopathy, Familial Hypertrophic, 13
|
0.900 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Cardiomyopathy, Familial Hypertrophic, 13
|
0.900 |
Biomarker
|
disease |
CTD_human |
|
|
|
Cardiomyopathy, Dilated, 1z
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes.
|
30681346 |
2019 |
Cardiomyopathy, Dilated, 1z
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples.
|
27532257 |
2017 |
Cardiomyopathy, Dilated, 1z
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
The genetics of dilated cardiomyopathy.
|
20186049 |
2010 |
Cardiomyopathy, Dilated, 1z
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Severe disease expression of cardiac troponin C and T mutations in patients with idiopathic dilated cardiomyopathy.
|
15542288 |
2004 |
Cardiomyopathy, Dilated, 1z
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Cardiomyopathy, Dilated, 1z
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Hypertrophic Cardiomyopathy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Characterization of the L29Q Hypertrophic Cardiomyopathy Mutation in Cardiac Troponin C by Paramagnetic Relaxation Enhancement Nuclear Magnetic Resonance.
|
30620548 |
2019 |
Hypertrophic Cardiomyopathy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
We used a murine model of hypertrophic cardiomyopathy (HCM) harboring a cardiac troponin C (cTnC) Ca<sup>2+</sup>-sensitizing mutation, Ala8Val in the regulatory N-domain.
|
30138628 |
2018 |
Hypertrophic Cardiomyopathy
|
0.500 |
GeneticVariation
|
disease |
CLINVAR |
Hypertrophic Cardiomyopathy Cardiac Troponin C Mutations Differentially Affect Slow Skeletal and Cardiac Muscle Regulation.
|
28473771 |
2017 |
Hypertrophic Cardiomyopathy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Therefore, we reconstituted rabbit soleus fibers and bovine masseter myofibrils with mutant cTnCs (A8V, C84Y, E134D, and D145E) associated with HCM to investigate their effects on contractile force and ATPase rates, respectively.
|
28473771 |
2017 |
Hypertrophic Cardiomyopathy
|
0.500 |
GeneticVariation
|
disease |
CLINVAR |
Changes in the dynamics of the cardiac troponin C molecule explain the effects of Ca2+-sensitizing mutations.
|
28533433 |
2017 |
Hypertrophic Cardiomyopathy
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Here, we used high-resolution electron-spray ionization mass spectrometry (ESI-MS), Carr-Purcell-Meiboom-Gill relaxation dispersion (CPMG-RD), and affinity measurements of cTnC for the thin filament in reconstituted papillary muscles to provide evidence of an allosteric mechanism in mutant cTnC that may play a role to the HCM phenotype.
|
28049727 |
2017 |
Hypertrophic Cardiomyopathy
|
0.500 |
GeneticVariation
|
disease |
CLINVAR |
Enhanced troponin I binding explains the functional changes produced by the hypertrophic cardiomyopathy mutation A8V of cardiac troponin C.
|
26976709 |
2016 |